Basilea Pharmaceutica revenue and financials
In the fiscal year ended December 2025, Basilea Pharmaceutica reported revenue of CHF 232.38M (+11.43% year over year). Net income was CHF 40.24M, a net margin of 17.3%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +11.43%
- 2025 vs 2024
- Net income growth
- −48.14%
- 2025 vs 2024
- Net margin
- 17.3%
- 2024: 37.2%
How Basilea Pharmaceutica is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 12.7% a year on average over the last 5 years
Compound annual growth rate: from CHF 127.63M in 2020 to CHF 232.38M in 2025.
Revenue has grown for 3 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from 14.1% to 22.5%
Operating income over revenue, 2022 → 2025: 8.4 percentage points.
Profits turn into cash: free cash flow equal to 113% of net income
Totals for fiscal years 2023–2025: free cash flow CHF 145.56M, net income CHF 128.28M.
Shares outstanding up 33.1% in 5 years
Average diluted shares, 2020 → 2025: with more shares, each one represents a smaller stake in the company (dilution).
Profitable in 4 of 5 fiscal years
Positive net income, fiscal years 2021–2025.
Financial data
Amounts in millions of CHF; per-share values in CHF; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 232 | 209 | 158 | 148 | 148 | 128 | 134 | 133 | 102 | 66.0 |
| Cost of revenue | 145 | 116 | 105 | 98.4 | 117 | 121 | 122 | 125 | 64.1 | 53.8 |
| Gross profit | 87.2 | 92.7 | 53.0 | 49.4 | 30.9 | 6.2 | 12.9 | 7.3 | 37.4 | 12.2 |
| Selling, general and administrative | 34.9 | 31.0 | 31.1 | 28.5 | 27.9 | 27.6 | 28.5 | 30.5 | 51.6 | 56.1 |
| Research and development | 106 | 77.1 | 77.9 | 73.8 | — | — | — | — | — | — |
| Operating income | 52.2 | 61.7 | 21.9 | 20.8 | 3.0 | -21.4 | -15.7 | -23.2 | -14.1 | -43.9 |
| EBIT | 52.2 | 61.7 | 21.9 | 20.8 | 3.0 | -21.4 | -15.7 | -23.2 | -14.1 | -43.9 |
| EBITDA | 54.1 | 63.4 | 23.2 | 21.7 | 3.6 | -20.3 | -14.1 | -21.4 | -12.2 | -41.7 |
| Interest expense | 3.4 | 4.3 | 11.2 | 9.8 | 8.2 | 7.6 | 6.4 | 6.6 | 6.7 | 6.4 |
| Pre-tax income | 45.9 | 60.3 | 10.5 | 12.1 | -6.8 | -14.7 | -22.4 | -31.2 | -19.0 | -51.0 |
| Income tax | 5.6 | -17.3 | 0.0 | -0.0 | 0.0 | 0.1 | 0.0 | 0.2 | 0.3 | 0.3 |
| Net income | 40.2 | 77.6 | 10.5 | 12.1 | -6.8 | -14.7 | -22.4 | -31.4 | -19.4 | -51.3 |
| Net income to common shareholders | 40.2 | 77.6 | 10.5 | 12.1 | -6.8 | -14.7 | -22.4 | -31.4 | -19.4 | -51.3 |
| Basic EPS | 3.29 | 6.42 | 0.87 | 1.02 | -0.58 | -1.43 | -2.08 | -2.89 | -1.79 | -5.07 |
| Diluted EPS | 3.14 | 5.82 | 0.86 | 1.02 | -0.58 | -1.43 | -2.08 | -2.89 | -1.79 | -5.07 |
| Average shares (basic) | 12.2 | 12.1 | 12.0 | 11.9 | 11.7 | 10.3 | 10.8 | 10.8 | 10.8 | 10.1 |
| Average shares (diluted) | 13.7 | 13.9 | 12.1 | 11.9 | 11.7 | 10.3 | 10.8 | 10.8 | 10.8 | 10.1 |
Amounts in millions of CHF; per-share values in CHF; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 119 | 128 | 104 | 132 | 76.3 | 72.7 | 84.9 | 90.1 | 57.6 | 93.9 |
| Cost of revenue | 69.5 | 82.7 | 62.5 | 64.1 | 51.7 | 73.2 | 31.5 | 46.3 | 52.1 | 62.0 |
| Gross profit | 49.5 | 45.7 | 41.4 | 68.1 | 24.6 | -0.5 | 53.4 | 43.8 | 5.6 | 31.9 |
| Selling, general and administrative | 17.5 | 17.9 | 17.1 | 16.0 | 15.1 | 15.9 | 15.2 | 14.2 | 14.4 | 14.4 |
| Operating income | 32.0 | 27.9 | 24.4 | 52.2 | 9.5 | -16.4 | 38.3 | 29.6 | -8.8 | 17.5 |
| EBIT | 32.0 | 27.9 | 24.4 | 52.2 | 9.5 | -16.4 | 38.3 | 29.6 | -8.8 | 17.5 |
| EBITDA | 32.1 | 29.0 | 25.2 | 53.3 | 10.2 | -15.8 | 38.9 | 30.2 | -8.5 | 17.7 |
| Interest expense | 1.4 | 1.4 | 1.9 | 1.8 | 2.5 | 5.4 | 5.8 | 6.0 | 3.8 | 4.0 |
| Pre-tax income | 32.1 | 26.5 | 19.3 | 52.9 | 7.3 | -21.4 | 31.9 | 24.3 | -12.2 | 13.1 |
| Income tax | 4.2 | 2.1 | 3.5 | -3.9 | -13.4 | -0.0 | 0.0 | -0.0 | -0.0 | 0.0 |
| Net income | 27.9 | 24.4 | 15.8 | 56.9 | 20.7 | -21.4 | 31.8 | 24.4 | -12.2 | 13.1 |
| Net income to common shareholders | 27.9 | 24.4 | 15.8 | 56.9 | 20.7 | -21.4 | 31.8 | 24.4 | -12.2 | 13.1 |
| Basic EPS | 2.26 | 2.00 | 1.29 | 4.70 | 1.72 | -1.78 | 2.66 | 2.05 | -1.03 | 1.11 |
| Diluted EPS | 2.12 | 1.89 | 1.26 | 4.20 | 1.61 | -1.90 | 2.42 | 2.02 | -1.03 | 1.11 |
| Average shares (basic) | 12.4 | 12.2 | 12.2 | 12.1 | 12.1 | 12.0 | 12.0 | 11.9 | 11.8 | 11.8 |
| Average shares (diluted) | 13.8 | 13.5 | 13.8 | 13.9 | 13.8 | 12.0 | 13.8 | 12.0 | 11.8 | 11.8 |
Amounts in millions of CHF; per-share values in CHF; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 282 | 258 | 173 | 221 | 247 | 230 | 221 | 282 | 351 | 328 |
| Current assets | 252 | 221 | 152 | 175 | 241 | 224 | 185 | 275 | 293 | 268 |
| Cash and equivalents | 160 | 121 | 59.9 | 84.7 | 53.7 | 60.7 | 109 | 173 | 201 | 239 |
| Short-term investments | — | — | — | — | 95.0 | 101 | 20.0 | 50.0 | 60.0 | — |
| Receivables | 63.3 | 58.2 | 58.1 | 61.7 | 64.4 | 32.4 | 28.3 | 34.7 | 15.0 | 7.4 |
| Inventory | 21.6 | 31.6 | 26.4 | 24.2 | 22.8 | 21.2 | 18.6 | 14.4 | 15.3 | 14.9 |
| Net property, plant and equipment | 18.2 | 19.0 | 20.6 | 21.6 | 2.9 | 5.3 | 6.1 | 6.4 | 7.8 | 8.9 |
| Other intangible assets | 0.4 | 0.4 | 0.5 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.3 | 0.2 |
| Long-term investments | — | — | — | — | — | — | 30.0 | — | 50.0 | 50.0 |
| Current liabilities | 49.2 | 45.6 | 47.6 | 74.9 | 174 | 50.2 | 75.5 | 66.7 | 79.5 | 72.9 |
| Accounts payable | 15.1 | 11.5 | 5.8 | 0.2 | 10.6 | 13.2 | 6.8 | 6.4 | 4.4 | 1.9 |
| Long-term debt | 75.4 | 95.9 | 95.5 | 131 | 94.5 | 240 | 198 | 197 | 196 | 195 |
| Total debt | 89.2 | 112 | 129 | 187 | 219 | 242 | 199 | 197 | 196 | 195 |
| Total liabilities | 154 | 177 | 183 | 242 | 306 | 332 | 314 | 348 | 393 | 363 |
| Total equity (incl. minority) | 128 | 81.0 | -10.0 | -20.7 | -58.6 | -102 | -93.0 | -66.7 | -41.4 | -35.0 |
| Retained earnings | -883 | -923 | -1,001 | -1,011 | -1,023 | -1,016 | -1,002 | -979 | -951 | -931 |
Amounts in millions of CHF; per-share values in CHF; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 298 | 282 | 249 | 258 | 189 | 173 | 230 | 221 | 236 | 247 |
| Current assets | 274 | 252 | 217 | 221 | 155 | 152 | 186 | 175 | 212 | 241 |
| Cash and equivalents | 173 | 160 | 128 | 121 | 63.0 | 59.9 | 87.7 | 84.7 | 45.7 | 53.7 |
| Short-term investments | — | — | — | — | — | — | — | — | 95.0 | 95.0 |
| Receivables | 68.2 | 63.3 | 57.3 | 58.2 | 48.9 | 58.1 | 64.4 | 61.7 | 38.6 | 64.4 |
| Inventory | 26.0 | 21.6 | 22.6 | 31.6 | 31.4 | 26.4 | 25.6 | 24.2 | 24.8 | 22.8 |
| Net property, plant and equipment | 16.8 | 18.2 | 17.5 | 19.0 | 19.4 | 20.6 | 21.7 | 21.6 | 21.6 | 2.9 |
| Other intangible assets | 0.2 | 0.4 | 0.3 | 0.4 | 0.5 | 0.5 | 0.5 | 0.6 | 1.2 | 0.6 |
| Long-term investments | — | — | — | — | — | — | — | — | 1.3 | — |
| Current liabilities | 41.5 | 49.2 | 34.4 | 45.6 | 37.8 | 47.6 | 67.2 | 74.9 | 155 | 174 |
| Accounts payable | 14.0 | 15.1 | 9.9 | 11.5 | 11.5 | 5.8 | 3.9 | 0.2 | 4.7 | 10.6 |
| Long-term debt | 70.6 | 75.4 | 82.0 | 95.9 | 95.7 | 95.5 | 113 | 131 | 94.8 | 94.5 |
| Total debt | 83.4 | 89.2 | 96.8 | 112 | 112 | 129 | 170 | 187 | 231 | 219 |
| Total liabilities | 136 | 154 | 146 | 177 | 172 | 183 | 215 | 242 | 303 | 306 |
| Total equity (incl. minority) | 162 | 128 | 103 | 81.0 | 16.8 | -10.0 | 15.0 | -20.7 | -67.2 | -58.6 |
| Retained earnings | -855 | -883 | -907 | -923 | -980 | -1,001 | -979 | -1,011 | -1,035 | -1,023 |
Amounts in millions of CHF; per-share values in CHF; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 62.1 | 74.4 | 14.2 | 7.1 | -32.0 | -54.1 | -63.8 | -79.2 | 19.0 | -75.0 |
| Depreciation and amortization | 3.7 | 3.5 | 3.2 | 2.7 | 2.3 | 2.2 | 1.9 | 1.8 | 1.9 | 2.2 |
| Capital expenditure | -2.6 | -1.7 | -0.8 | -3.1 | -0.6 | -1.8 | -0.3 | -0.4 | -0.7 | -0.4 |
| Investing cash flow | -2.9 | -1.0 | -1.0 | 91.6 | 3.6 | -35.0 | -0.4 | 59.4 | -60.9 | 1.2 |
| Financing cash flow | -21.4 | -13.2 | -57.3 | -45.2 | 16.6 | 45.1 | 1.3 | -6.0 | 2.6 | 0.4 |
| Share repurchases | — | 0.0 | -0.4 | — | -4.3 | — | — | -6.2 | — | — |
| Debt issued | — | — | 0.0 | 73.9 | 0.0 | 97.1 | — | — | — | — |
| Debt repaid | -22.0 | -15.6 | -59.3 | 0.0 | — | — | — | — | — | — |
| Effect of exchange rates | -0.0 | 0.1 | -0.2 | 0.2 | 0.5 | -0.8 | 0.1 | -1.0 | 1.0 | -0.7 |
| Net change in cash | 37.8 | 60.2 | -44.2 | 53.6 | -11.3 | -44.8 | -62.9 | -26.8 | -38.3 | -74.0 |
| Free cash flow | 59.5 | 72.7 | 13.4 | 3.9 | -32.6 | — | — | — | — | — |
| Levered free cash flow | 49.2 | 48.7 | 8.5 | -2.4 | -25.2 | -46.0 | -4.0 | -42.5 | -2.8 | -25.9 |
Amounts in millions of CHF; per-share values in CHF; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 19.0 | 39.0 | 23.1 | 56.4 | 17.9 | -7.6 | 21.9 | 6.9 | 0.1 | -4.9 |
| Depreciation and amortization | 1.0 | 2.8 | 1.0 | 2.8 | 0.7 | 2.5 | 0.7 | 1.4 | 1.3 | 2.0 |
| Capital expenditure | -0.4 | -2.3 | -0.3 | -1.2 | -0.5 | -0.5 | -0.3 | -1.5 | -1.6 | -0.3 |
| Investing cash flow | -0.4 | -2.4 | -0.4 | -1.3 | 0.3 | -0.6 | -0.4 | 94.0 | -2.3 | -15.5 |
| Financing cash flow | -4.9 | -7.0 | -14.5 | -0.0 | -13.1 | -40.2 | -17.1 | -38.5 | -6.8 | -9.6 |
| Share repurchases | — | — | — | — | — | — | — | — | -0.1 | -0.6 |
| Debt issued | — | — | — | — | — | — | — | 73.9 | — | — |
| Debt repaid | — | — | — | 0.0 | -15.6 | -40.9 | -18.4 | — | — | — |
| Effect of exchange rates | -0.0 | -0.0 | -0.0 | -0.1 | 0.1 | -0.1 | -0.0 | -0.7 | 0.8 | 0.3 |
| Net change in cash | 13.6 | 29.6 | 8.2 | 55.1 | 5.1 | -48.6 | 4.4 | 61.7 | -8.1 | -29.7 |
| Free cash flow | 18.6 | 36.7 | 22.7 | 55.2 | 17.5 | -8.1 | 21.6 | 5.4 | -1.5 | -5.2 |
| Levered free cash flow | 6.1 | 31.4 | 17.7 | 35.3 | 13.4 | 0.5 | 8.0 | -3.3 | 0.9 | -8.1 |
Financial statements of similar companies
Companies in the group: same industry, similar size
